α-Cyperone alleviates lung cell injury caused by Staphylococcus aureus via attenuation of α-Hemolysin expression

Journal of Microbiology and Biotechnology

Volumn 22, Issue 8, 2012, Pages 1170-1176

  Luo, M ^a   Qiu, J ^a   Zhang, Y ^a   Wang, J ^a   Dong, J ^a   Li, H ^a   Leng, B ^a   Zhang, Q ^a   Dai, X ^a   Niu, X ^a   Zhao, S ^b   Deng, X ^a  

^a JILIN UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

cyperone; hemolysin; Antivirulence; Staphylococcus aureus

Indexed keywords

ALPHA CYPERONE; ALPHA HEMOLYSIN; LACTATE DEHYDROGENASE; SESQUITERPENE; UNCLASSIFIED DRUG;

ACCESSORY GENE REGULATOR; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; CELL DAMAGE; CELL DEATH; CELL DENSITY; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG STRUCTURE; ENZYME RELEASE; GENE EXPRESSION; HEMOLYSIS; HLA GENE; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MINIMUM INHIBITORY CONCENTRATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; SUPERNATANT; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; GENE EXPRESSION; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84863994185     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1202.02017     Document Type: Article

References (36)

1. Bhakdi, S. and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55: 733-751.
2. Boyle-Vavra, S. and R.S. Daum. 2007. Community-acquired methicillin-resistant Staphylococcus aureus: The role of Panton-Valentine leukocidin. Lab. Invest. 87: 3-9.
3. Bramley, A.J., A.H. Patel, M. O'Reilly, R. Foster, and T.J. Foster. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57: 2489-2494.
4. Bubeck Wardenburg, J., T. Bae, M. Otto, F.R. Deleo, and O. Schneewind. 2007. Poring over pores: Alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13: 1405-1406.
5. Callegan, M.C., L.S. Engel, J.M. Hill, and R.J. O'Callaghan. 1994. Corneal virulence of Staphylococcus aureus: Roles of alpha-toxin and protein A in pathogenesis. Infect. Immun. 62: 2478-2482.
6. Cegelski, L., G.R. Marshall, G.R. Eldridge, and S.J. Hultgren. 2008. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6: 17-27.
7. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI/NCCLS document; M100-S15.
8. Gouaux, E. 1998. α-Hemolysin from Staphylococcus aureus: An archetype of β-barrel, channel-forming toxins. J. Struct. Biol. 121: 110-122.
9. Jia, W., X. Wang, D. Xu, A. Zhao, and Y. Zhang. 2006. Common traditional Chinese medicinal herbs for dysmenorrhea. Phytother. Res. 20: 819-824.
10. Kilani, S., M. Ben Sghaier, I. Limem, I. Bouhlel, J. Boubaker, W. Bhouri, et al. 2008. In vitro evaluation of antibacterial, antioxidant, cytotoxic and apoptotic activities of the tubers infusion and extracts of Cyperus rotundus. Bioresour. Technol. 99: 9004-9008.
11. Kilani, S., I. Bouhlel, R. Ben Ammar, M. Ben Sghair, I. Skandrani, J. Boubaker, et al. 2007. Chemical investigation of different extracts and essential oil from the tubers of (Tunisian) Cyperus rotundus. Correlation with their antiradical and antimutagenic properties. Ann. Microbiol. 57: 657-664.
12. Kilani, S., J. Ledauphin, I. Bouhlel, M. Ben Sghaier, J. Boubaker, I. Skandrani, et al. 2008. Comparative study of Cyperus rotundus essential oil by a modified GC/MS analysis method. Evaluation of its antioxidant, cytotoxic, and apoptotic effects. Chem. Biodivers. 5: 729-742.
13. Klevens, R.M., M.A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
14. Kollef, M.H., L.E. Morrow, M.S. Niederman, K.V. Leeper, A. Anzueto, L. Benz-Scott, and F.J. Rodino. 2006. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 129: 1210-1218.
15. Kuehnert, M.J., H.A. Hill, B.A. Kupronis, J.I. Tokars, S.L. Solomon, and D.B. Jernigan. 2005. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg. Infect. Dis. 11: 868-872.
16. Labandeira-Rey, M., F. Couzon, S. Boisset, E.L. Brown, M. Bes, Y. Benito, et al. 2007. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315: 1130-1133.
17. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
18. Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M.O. Peter, V. Gauduchon, et al. 1999. Involvement of Panton-V a le n tin e leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29: 1128-1132.
19. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
20. Mandell, L.A., R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, N.C. Dean, et al. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44: S27-S72.
21. McElroy, M.C., H.R. Harty, G.E. Hosford, G.M. Boylan, J.F. Pittet, and T.J. Foster. 1999. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect. Immun. 67: 5541-5544.
22. Ohlsen, K., W. Ziebuhr, K.P. Koller, W. Hell, T.A. Wichelhaus, and J. Hacker. 1998. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 42: 2817-2823.
23. Patel, A.H., P. Nowlan, E.D. Weavers, and T. Foster. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55: 3103-3110.
24. Qiu, J.Z., M.J. Luo, J.F. Wang, J. Dong, H.E. Li, B.F. Leng, et al. 2011. Isoalantolactone protects against Staphylococcus aureus pneumonia. FEMS Microbiol. Lett. 324: 147-155.
25. Ragle, B.E., V.A. Karginov, and J.B. Wardenburg. 2010. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob. Agents Chemother. 54: 298-304.
26. Ragle, B.E. and J.B. Wardenburg. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77: 2712-2718.
27. Rasko, D.A. and V. Sperandio. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9: 117-128.
28. Raut, N.A. and N.J. Gaikwad. 2006. Antidiabetic activity of hydro-ethanolic extract of Cyperus rotundus in alloxan induced diabetes in rats. Fitoterapia 77: 585-588.
29. Rowe, G.E. and R.A. Welch. 1994. Assays of hemolytic toxins. Methods Enzymol. 235: 657-667.
30. Rubin, R.J., C.A. Harrington, A. Poon, K. Dietrich, J.A. Greene, and A. Moiduddin. 1999. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5: 9-17.
31. Sambanthamoorthy, K., M.S. Smeltzer, and M.O. Elasri. 2006. Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus. Microbiology 152: 2559-2572.
32. Song, L., M.R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, and J.E. Gouaux. 1996. Structure of staphylococcal α-hemolysin, a heptameric transmembrane pore. Science 274: 1859-1866.
33. Wang, J., J. Qiu, J. Dong, H. Li, M. Luo, X. Dai, et al. 2011. Chrysin protects mice from Staphylococcus aureus pneumonia. J. Appl. Microbiol. 111: 1551-1558.
34. Wardenburg, J.B., A.M. Palazzolo-Ballance, M. Otto, O. Schneewind, and F.R. DeLeo. 2008. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J. Infect. Dis. 198: 1166-1170.
35. Wardenburg, J.B., R.J. Patel, and O. Schneewind. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75: 1040-1044.
36. Wardenburg, J.B. and O. Schneewind. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205: 287-294.